US Bancorp
VIVO

US Bancorp’s Meridian Bioscience Inc VIVO Stock Holding History

US Bancorp’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,402
Closed -$79.8K – 4260
2022
Q4 		$79.8K Sell
2,402
-28
-1% -$902 ﹤0.01% 2294
2022
Q3 		$76K Sell
2,430
-359
-13% -$11.6K ﹤0.01% 2314
2022
Q2 		$84K Buy
2,789
+85
+3% +$2.3K ﹤0.01% 2331
2022
Q1 		$70K Sell
2,704
-651
-19% -$15.5K ﹤0.01% 2450
2021
Q4 		$69K Sell
3,355
-288
-8% -$5.52K ﹤0.01% 2479
2021
Q3 		$70K Sell
3,643
-23,126
-86% -$461K ﹤0.01% 2483
2021
Q2 		$593K Sell
26,769
-63
-0.2% -$1.34K ﹤0.01% 1456
2021
Q1 		$704K Sell
26,832
-1,303
-5% -$31K ﹤0.01% 1324
2020
Q4 		$526K Buy
28,135
+1,953
+7% +$36.5K ﹤0.01% 1412
2020
Q3 		$445K Buy
26,182
+21,172
+423% +$411K ﹤0.01% 1387
2020
Q2 		$116K Buy
5,010
+3,680
+277% +$53.3K ﹤0.01% 2030
2020
Q1 		$11K Sell
1,330
-692
-34% -$5.83K ﹤0.01% 3010
2019
Q4 		$20K Buy
2,022
+286
+16% +$2.69K ﹤0.01% 2896
2019
Q3 		$16K Sell
1,736
-314
-15% -$3.31K ﹤0.01% 2933
2019
Q2 		$25K Sell
2,050
-311
-13% -$3.75K ﹤0.01% 2804
2019
Q1 		$41K Sell
2,361
-240
-9% -$3.99K ﹤0.01% 2583
2018
Q4 		$45K Hold
2,601
– – ﹤0.01% 2503
2018
Q3 		$38K Buy
2,601
+1,200
+86% +$18.6K ﹤0.01% 2691
2018
Q2 		$22K Sell
1,401
-1,662
-54% -$24.8K ﹤0.01% 2911
2018
Q1 		$44K Sell
3,063
-503
-14% -$7.44K ﹤0.01% 2680
2017
Q4 		$50K Sell
3,566
-854
-19% -$12.5K ﹤0.01% 2607
2017
Q3 		$63K Hold
4,420
– – ﹤0.01% 2467
2017
Q2 		$70K Buy
4,420
+934
+27% +$13.5K ﹤0.01% 2377
2017
Q1 		$48K Buy
3,486
+179
+5% +$2.5K ﹤0.01% 2523
2016
Q4 		$58K Buy
3,307
+150
+5% +$2.63K ﹤0.01% 2369
2016
Q3 		$61K Hold
3,157
– – ﹤0.01% 2341
2016
Q2 		$61K Hold
3,157
– – ﹤0.01% 2309
2016
Q1 		$65K Sell
3,157
-300
-9% -$5.91K ﹤0.01% 2250
2015
Q4 		$71K Hold
3,457
– – ﹤0.01% 2264
2015
Q3 		$59K Sell
3,457
-300
-8% -$5.48K ﹤0.01% 2373
2015
Q2 		$70K Buy
3,757
+900
+32% +$16.7K ﹤0.01% 2351
2015
Q1 		$54K Buy
2,857
+500
+21% +$9.25K ﹤0.01% 2508
2014
Q4 		$39K Hold
2,357
– – ﹤0.01% 2648
2014
Q3 		$42K Sell
2,357
-945
-29% -$18.6K ﹤0.01% 2574
2014
Q2 		$68K Sell
3,302
-4,062
-55% -$83.5K ﹤0.01% 2343
2014
Q1 		$161K Sell
7,364
-173
-2% -$3.96K ﹤0.01% 1882
2013
Q4 		$200K Buy
7,537
+3,050
+68% +$75K ﹤0.01% 1729
2013
Q3 		$107K Hold
4,487
– – ﹤0.01% 2001
2013
Q2 		$97K Buy
+4,487
New +$96.8K ﹤0.01% 2012

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

US Bancorp's VIVO Position: Q1 2023 in Review

US Bancorp sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,402 shares — an estimated $79.8K sold.

US Bancorp first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $704K in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • US Bancorp reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • US Bancorp sold 2,402 Meridian Bioscience Inc shares in Q1 2023, an estimated $79.8K.
  • US Bancorp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • US Bancorp's Meridian Bioscience Inc position peaked at $704K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.